544 studies found for:    United States, Vermont | University of Vermont
Show Display Options
Rank Status Study
21 Recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Carcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation;   Endometrial Serous Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Cisplatin;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy
22 Active, not recruiting
Has Results
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: Dasatinib;   Other: Pharmacological Study
23 Completed Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Condition: Dengue
Interventions: Biological: V180;   Biological: Alhydrogel™;   Biological: Placebo
24 Recruiting Pre-Emptive Analgesia in Ano-Rectal Surgery
Conditions: Hemorrhoids;   Fissure in Ano;   Rectal Fistula;   Anal Condyloma
Interventions: Drug: Gabapentin;   Drug: Ketamine;   Drug: Acetaminophen;   Drug: Dexamethasone;   Drug: Placebo
25 Recruiting A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Non-Small Cell Lung Cancer (ALK-positive);   Non-Small Cell Lung Cancer (c-Met Dependent);   Non-Small Cell Lung Cancer (ROS Marker Positive);   Systemic Anaplastic Large-Cell Lymphoma;   Advanced Malignancies (Except Leukemia)
Interventions: Drug: PF-02341066;   Drug: Rifampin;   Drug: Itraconazole
26 Enrolling by invitation Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
Conditions: Arthritis;   Asthma;   Chronic Obstructive Lung Disease;   Diabetes;   Heart Failure;   Hypertension;   Anxiety;   Chronic Pain;   Depression;   Fibromyalgia;   Insomnia;   Irritable Bowel Syndrome;   Problem Drinking;   Substance Use Disorder
Intervention: Other: Integration
27 Not yet recruiting Incentivizing Physical Activity Using Ramification, A Pilot Study
Conditions: Obesity;   Physical Activity
Interventions: Behavioral: gaming application to encourage physical activity;   Device: FitBit
28 Recruiting Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Condition: Substance Withdrawal Syndrome
Intervention: Behavioral: Abstinence from e-cigarettes
29 Recruiting Bemobile Intervention to Support Physical Activity in Cancer Survivors
Condition: Cancer
Intervention: Behavioral: Bemobile
30 Active, not recruiting Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
Condition: Opioid Use Disorders
Interventions: Drug: CAM2038 subcutaneous injection;   Drug: SL BPN tablets;   Drug: placebo subcutaneous (SC) injections;   Drug: SL placebo tablets
31 Recruiting A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GED-0301;   Other: Placebo
32 Recruiting Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
33 Withdrawn Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Intervention: Drug: H.P. Acthar® Gel
34 Active, not recruiting Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Condition: Obesity
Interventions: Behavioral: Nutrition facts automatically or not automatically displayed;   Behavioral: Nutrition facts in color;   Behavioral: Nutrition Facts Label in Larger Font;   Behavioral: Healthier Items First
35 Enrolling by invitation VX15/2503 Treatment for Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: VX15/2503;   Drug: Placebo
36 Active, not recruiting Role of Magnesium Supplementation in the Treatment of Depression
Condition: Depression
Intervention: Drug: Magnesium chloride
37 Recruiting Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: abicipar pegol;   Drug: ranibizumab;   Other: sham procedure
38 Recruiting Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
Condition: Dengue
Interventions: Biological: Recombinant live attenuated trivalent dengue vaccine;   Biological: Placebo;   Biological: rDEN2Δ30-7169 vaccine
39 Not yet recruiting Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers
Condition: Tobacco Use Disorder
Intervention: Other: Very low nicotine content cigarettes
40 Not yet recruiting Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women
Condition: Tobacco Use Disorder
Intervention: Other: Very low nicotine content cigarettes

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years